Ju Han Kim

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Comparative analysis of metazoan chromatin organization

Joshua W. K. Ho, Youngsook L. Jung, Tao Liu et al. · Nature · 2014 · 416 citations · Full text

Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records

Hun‐Sung Kim, Suehyun Lee, Ju Han Kim · Journal of Korean Medical Science · 2018 · 391 citations · Full text

Evidence-based Therapy, Privacy Protection, Health Policy +14

The <i>Orientia tsutsugamushi</i> genome reveals massive proliferation of conjugative type IV secretion system and host–cell interaction genes

Nam‐Hyuk Cho, Hang‐Rae Kim, Jung‐Hee Lee et al. · Proceedings of the National Academy of Sciences · 2007 · 230 citations · Full text

Reverse Genetics, Genetics, Genomic Mechanism +18